Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sansure Biotech's share price for the quarter that ended in Mar. 2026 was ¥18.06. Sansure Biotech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 579 Mil. Therefore, Sansure Biotech's market cap for the quarter that ended in Mar. 2026 was ¥10,464 Mil.
Sansure Biotech's quarterly market cap
declined
from Sep. 2025 (¥12,266 Mil) to Dec. 2025 (¥10,956 Mil) and
declined
from Dec. 2025 (¥10,956 Mil) to Mar. 2026 (¥10,464 Mil).
Sansure Biotech's annual market cap
increased
from Dec. 2023 (¥11,504 Mil) to Dec. 2024 (¥13,220 Mil) but then
declined
from Dec. 2024 (¥13,220 Mil) to Dec. 2025 (¥10,956 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sansure Biotech's Enterprise Value for Today is ¥6,089 Mil.
Sansure Biotech (SHSE:688289) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sansure Biotech Market Cap Related Terms
Sansure Biotech Market Cap Historical Data
* Premium members only.
The historical data trend for Sansure Biotech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688289 vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Sansure Biotech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sansure Biotech Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sansure Biotech's Market Cap distribution charts can be found below:
* The bar in red indicates where Sansure Biotech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sansure Biotech's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sansure Biotech (SHSE:688289) has a Market Cap of ¥8,424 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sansure Biotech and its competitors. According to the industry distribution chart, Sansure Biotech ranks #156 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 18%.
Is Sansure Biotech's Market Cap too high?
Sansure Biotech's current Market Cap is ¥8,424 Mil. Based on the distribution chart, Sansure Biotech ranks #156 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sansure Biotech has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sansure Biotech's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sansure Biotech ranks #156 out of 868 companies for Market Cap. This places Sansure Biotech in the top 18% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.35, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sansure Biotech and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sansure Biotech's current Market Cap is ¥8,424 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sansure Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sansure Biotech (SHSE:688289) is currently considered Possible Value Trap. The stock's GF Value™ is ¥20.69, compared to a current price of ¥14.54 — trading 29.7% below its estimated fair value. The current Market Cap is ¥8,424 Mil. Sansure Biotech's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sansure Biotech (SHSE:688289), the current Market Cap is ¥8,424 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sansure Biotech (SHSE:688289) Overvalued in 2026?
Based on GuruFocus' analysis, Sansure Biotech stock appears to be undervalued.
The current stock price of ¥14.54 is trading 29.7% below its estimated GF Value™ of ¥20.69.
GuruFocus considers Sansure Biotech to be Possible Value Trap.
Key valuation signals for SHSE:688289:
Market Cap: ¥8,424 Mil
GF Value™: ¥20.69 vs. price of ¥14.54 (29.7% below fair value)
No single metric tells the full story. See the SHSE:688289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688289 has been successfully added to your 
